Cardiac Imaging In The VALOR-HCM Trial Cardiac Consult: A Cleveland Clinic Podcast For Healthcare Professionals podcast

Artwork

Fitness Cardiac Consult: For Healthcare Professionals Cleveland Clinic Vascular Institute Cleveland Clinic Heart Health Industry Health and Well-Being Health Care

Innhold levert av Cleveland Clinic Heart & Vascular Institute, Cleveland Clinic Heart, and Vascular Institute. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Cleveland Clinic Heart & Vascular Institute, Cleveland Clinic Heart, and Vascular Institute eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals « »
Cardiac Imaging in the VALOR-HCM Trial

27d ago 31:28

Del

MP3•Episoder hjem

Innhold levert av Cleveland Clinic Heart & Vascular Institute, Cleveland Clinic Heart, and Vascular Institute. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Cleveland Clinic Heart & Vascular Institute, Cleveland Clinic Heart, and Vascular Institute eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

Mavacamten is the first and only FDA-approved cardiac myosin inhibitor to treat obstructive hypertrophic cardiomyopathy (HCM). An important factor to the success of the VALOR HCM trial was the participation of specialized cardiac sonographers and imagers.
Milind Desai, MD, MBA speaks with Jeanne Drinko, Amy Kanta and Anne Campbell about the importance of cardiac imaging.
Learn more about C5 Research at Cleveland Clinic.
https://my.clevelandclinic.org/research/c5research
Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET), toll-free 800.223.2273, ext. 49162

… continue reading

301 episoder

#Fitness #Cardiac Consult: For Healthcare Professionals #Cleveland Clinic #Vascular Institute #Cleveland Clinic Heart #Health Industry #Health and Well-Being #Health Care

Artwork

Cardiac Imaging in the VALOR-HCM Trial

Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals

42 subscribers

published 27d ago

Del

MP3•Episoder hjem

Innhold levert av Cleveland Clinic Heart & Vascular Institute, Cleveland Clinic Heart, and Vascular Institute. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Cleveland Clinic Heart & Vascular Institute, Cleveland Clinic Heart, and Vascular Institute eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

Mavacamten is the first and only FDA-approved cardiac myosin inhibitor to treat obstructive hypertrophic cardiomyopathy (HCM). An important factor to the success of the VALOR HCM trial was the participation of specialized cardiac sonographers and imagers.
Milind Desai, MD, MBA speaks with Jeanne Drinko, Amy Kanta and Anne Campbell about the importance of cardiac imaging.
Learn more about C5 Research at Cleveland Clinic.
https://my.clevelandclinic.org/research/c5research
Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET), toll-free 800.223.2273, ext. 49162

… continue reading

301 episoder

#Fitness #Cardiac Consult: For Healthcare Professionals #Cleveland Clinic #Vascular Institute #Cleveland Clinic Heart #Health Industry #Health and Well-Being #Health Care

Semua episod

×

Velkommen til Player FM!

Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.

Lytt til 500+ tema